Form D · Pharmaceuticals

Nodal Therapeutics, Inc.

Silver Spring, MD · CIK 0002024197

Offering snapshot reported Oct 29, 2024 · SEC filing

Reported sold
$250K
Offering amount: $250K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 23, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$125K$250KJun 6, 2024: $100,000.00Jun 6, 2024Oct 29, 2024: $250,000.00Oct 29, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$100,000 → $250,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 29, 2024Amendment$250,000$150,000vs Jun 6, 20241SEC filing
Jun 6, 2024Initial$100,000No comparison1SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-515359
Simple Agreement for Future Equity

Source: Form D, filed Oct 29, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jonathan S. Bromberg Executive
Christopher Jewell Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1804 Edgewater Parkway
Silver Spring, MD, 20903